The endocannabinoid system (ECS) is vital in maintaining emotional balance, stress regulation, and reward processing. Chronic substance use disrupts this system, altering the function of cannabinoid receptors and the production of endocannabinoids. For example, excessive cannabis use desensitizes the CB1 receptor, leading to reduced natural reward responses and increased cravings. Similarly, other substances indirectly affect the ECS by impairing its interaction with neurotransmitter systems. This dysregulation contributes to withdrawal symptoms, heightened stress sensitivity, and difficulty sustaining sobriety. Emerging therapies aim to restore ECS function using receptor modulators, dietary changes, and physical activities that promote endocannabinoid balance. Understanding the ECS’s role in addiction provides a promising direction for personalized treatments that target the biological underpinnings of dependency. Such interventions can improve emotional stability, reduce relapse rates, and support long-term recovery.
Title : Tailoring biblio-poetry therapies using AI and biofeedback for addiction treatment
Nile Stanley, University of North Florida, United States
Title : The A-B-C of happiness coaching
Alphonsus Obayuwana, Triple-H Project LLC, United States
Title : Clinical pharmacology of marijuana: Update 2024
Frederick J Goldstein, Philadelphia College of Osteopathic Medicine, United States
Title : Trait-based recovery: Evidence-based trait activation to reduce depression, anxiety, and improve client engagement in addiction treatment
Jason Glenn Roop, The Center for Trait-Based Transformation, United States
Title : An investigation of the factors responsible for ubstance abuse from a cognitive perspective based on a mixed method approach
Adewole Olukorede, Literary Edifice, Italy
Title : A Long-Acting Naltrexone Implant (for Opioid Use Disorder: First-in-Human Phase I Trial)
Steven M Cohen, Akyso Therapeutics, United States